Squamous cell carcinoma and mammary abscess formation through squamous metaplasia in Smad4/Dpc4 conditional knockout mice

Development

Volumn 130, Issue 24, 2003, Pages 6143-6153

  Li, Wenmei ^a   Qiao, Wenhui ^a   Chen, Li ^a   Xu, Xiaoling ^a   Yang, Xiao ^a   Li, Dan ^a   Li, Cuiling ^a   Brodie, Steven G ^a   Meguid, Michael M ^b   Hennighausen, Lothar ^a   Deng, Chu Xia ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

Keratinocytes; Neoplasia; Smad4 Dpc4; TGF ; Transdifferentiation

Indexed keywords

BETA CATENIN; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEIN;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BREAST ABSCESS; BREAST DEVELOPMENT; BREAST EPITHELIUM; BREAST HYPERPLASIA; CELL DIFFERENTIATION; CELL FATE; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIUM CELL; GENE DISRUPTION; GENE INACTIVATION; KNOCKOUT MOUSE; MOUSE; MOUSE MUTANT; NONHUMAN; NULL ALLELE; PREGNANCY; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; SQUAMOUS CELL METAPLASIA; SQUAMOUS EPITHELIUM;

ABSCESS; ANIMALS; BETA CATENIN; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; CYTOSKELETAL PROTEINS; DNA-BINDING PROTEINS; EPIDERMIS; EPITHELIAL CELLS; EPITHELIUM; FEMALE; HUMANS; KERATINOCYTES; MAMMARY GLANDS, ANIMAL; METAPLASIA; MICE; MICE, KNOCKOUT; PREGNANCY; SIGNAL TRANSDUCTION; SMAD4 PROTEIN; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA;

ANIMALIA;

EID: 10744224096     PISSN: 09501991     EISSN: None     Source Type: Journal    
DOI: 10.1242/dev.00820     Document Type: Article

References (57)

1. Akhurst, R. J. (2002). TGF-beta antagonists: why suppress a tumor suppressor? J. Clin. Invest. 109, 1533-1536.
2. Akhurst, R. J. and Balmain, A. (1999). Genetic events and the role of TGF beta in epithelial tumour progression. J. Pathol. 187, 82-90.
3. Akiyama, T. (2000). Wnt/beta-catenin signaling. Cytokine Growth Factor Rev. 11, 273-282.
4. Arteaga, C. L., Carty-Dugger, T., Moses, H. L., Hurd, S. D. and Pietenpol, J. A. (1993). Transforming growth factor beta 1 can induce estrogen-independent tumorigenicity of human breast cancer cells in athymic mice. Cell Growth Differ 4, 193-201.
5. Barcellos-Hoff, M. H. and Ewan, K. B. (2000). Transforming growth factor-beta and breast cancer: Mammary gland development. Breast Cancer Res. 2, 92-99.
6. Bottinger, E. P., Jakubczak, J. L., Haines, D. C., Bagnall, K. and Wakefield, L. M. (1997a). Transgenic mice overexpressing a dominant-negative mutant type II transforming growth factor beta receptor show enhanced tumorigenesis in the mammary gland and lung in response to the carcinogen 7,12-dimethylbenz-[a]-anthracene. Cancer Res. 57, 5564-5570.
7. Bottinger, E. P., Jakubczak, J. L., Roberts, I. S., Mumy, M., Hemmati, P., Bagnall, K., Merlino, G. and Wakefield, L. M. (1997b). Expression of a dominant-negative mutant TGF-beta type II receptor in transgenic mice reveals essential roles for TGF-beta in regulation of growth and differentiation in the exocrine pancreas. EMBO J. 16, 2621-2633.
8. Boulanger, C. A. and Smith, G. H. (2001). Reducing mammary cancer risk through premature stem cell senescence. Oncogene 20, 2264-2272.
9. Brodie, S. G., Xu, X., Li, C., Kuo, A., Leder, P. and Deng, C. X. (2001). Inactivation of p53 tumor suppressor gene acts synergistically with c-neu oncogene in salivary gland tumorigenesis. Oncogene 20, 1445-1454.
10. Buggiano, V., Schere-Levy, C., Abe, K., Vanzulli, S., Piazzon, I., Smith, G. H. and Kordon, E. C. (2001). Impairment of mammary lobular development induced by expression of TGFbeta1 under the control of WAP promoter does not suppress tumorigenesis in MMTV-infected transgenic mice. Int. J. Cancer 92, 568-576.
11. Candidus, S., Bischoff, P., Becker, K. F. and Hofler, H. (1996). No evidence for mutations in the alpha- and beta-catenin genes in human gastric and breast carcinomas. Cancer Res. 56, 49-52.
12. Cardiff, R. D., Anver, M. R., Gusterson, B. A., Hennighausen, L., Jensen, R. A., Merino, M. J., Rehm, S., Russo, J., Tavassoli, F. A., Wakefield, L. M., Ward, J. M. and Green, J. E. (2000). The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting. Oncogene 19, 968-988.
13. Chakravarthy, D., Green, A. R., Green, V. L., Kerin, M. J. and Speirs, V. (1999). Expression and secretion of TGF-beta isoforms and expression of TGF-beta-receptors I, II and III in normal and neoplastic human breast. Int. J. Oncol. 15, 187-194.
14. Cui, W., Fowlis, D. J., Bryson, S., Duffie, E., Ireland, H., Balmain, A. and Akhurst, R. J. (1996). TGFbeta1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell 86, 531-542.
15. Daniel, C. W., Robinson, S. and Silberstein, G. B. (1996). The role of TGF-beta in patterning and growth of the mammary ductal tree. J. Mamm. Gland Biol. Neoplasia 1, 331-341.
16. Deng, C. X. and Brodie, S. G. (2001). Knockout mouse models and mammary tumorigenesis. Semin. Cancer Biol. 11, 387-394.
17. Derynck, R., Akhurst, R. J. and Balmain, A. (2001). TGF-beta signaling in tumor suppression and cancer progression. Nat. Genet. 29, 117-129.
18. Ellenrieder, V., Hendler, S. F., Boeck, W., Seufferlein, T., Menke, A., Ruhland, C., Adler, G. and Gress, T. M. (2001). Transforming growth factor beta 1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation. Cancer Res. 61, 4222-4228.
19. Engel, M. E., McDonnell, M. A., Law, B. K. and Moses, H. L. (1999). Interdependent SMAD and JNK signaling in transforming growth factor-beta-mediated transcription. J. Biol. Chem. 274, 37413-37420.
20. Friedl, W., Kruse, R., Uhlhaas, S., Stolte, M., Schartmann, B., Keller, K. M., Jungck, M., Stern, M., Loff, S., Back, W., Propping, P. and Jenne, D. E. (1999). Frequent 4-bp deletion in exon 9 of the SMAD4/MADH4 gene in familial juvenile polyposis patients. Genes Chromosomes Cancer 25, 403-406.
21. Gorska, A. E., Joseph, H., Derynck, R., Moses, H. L. and Serra, R. (1998). Dominant-negative interference of the transforming growth factor beta type II receptor in mammary gland epithelium results in alveolar hyperplasia and differentiation in virgin mice. Cell Growth Differ 9, 229-238.
22. Hahn, S. A., Hoque, A. T., Moskaluk, C. A., da Costa, L. T., Schutte, M., Rozenblum, E., Seymour, A. B., Weinstein, C. L., Yeo, C. J., Hruban, R. H. and Kern, S. E. (1996a). Homozygous deletion map at 18q21.1 in pancreatic cancer. Cancer Res. 56, 490-494.
23. Hahn, S. A., Schutte, M., Hoque, A. T., Moskaluk, C. A., da Costa, L. T., Rozenblum, E., Weinstein, C. L., Fischer, A., Yeo, C. J., Hruban, R. H. and Kern, S. E. (1996b). DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271, 350-353.
24. Heldin, C. H., Miyazono, K. and ten Dijke, P. (1997). TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 390, 465-471.
25. Hennighausen, L. and Robinson, G. W. (2001). Signaling pathways in mammary gland development. Dev. Cell 1, 467-475.
26. Hocevar, B. A., Brown, T. L. and Howe, P. H. (1999). TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway. EMBO J. 18, 1345-1356.
27. Howe, J. R., Roth, S., Ringold, J. C., Summers, R. W., Jarvinen, H. J., Sistonen, P., Tomlinson, I. P., Houlston, R. S., Bevan, S., Mitros, F. A., Stone, E. M. and Aaltonen, L. A. (1998). Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science 280, 1086-1088.
28. Joseph, H., Gorska, A. E., Sohn, P., Moses, H. L. and Serra, R. (1999). Overexpression of a kinase-deficient transforming growth factor-beta type II receptor in mouse mammary stroma results in increased epithelial branching. Mol. Biol. Cell 10, 1221-1234.
29. Karayiannakis, A. J., Nakopoulou, L., Gakiopoulou, H., Keramopoulos, A., Davaris, P. S. and Pignatelli, M. (2001). Expression patterns of beta-catenin in in situ and invasive breast cancer. Eur. J. Surg. Oncol. 27, 31-36.
30. Kretzschmar, M., Doody, J., Timokhina, I. and Massague, J. (1999). A mechanism of repression of TGFbeta/ Smad signaling by oncogenic Ras. Genes Dev. 13, 804-816.
31. Massague, J. (1998). TGF-beta signal transduction. Annu. Rev. Biochem. 67, 753-791.
32. Miyoshi, K., Shillingford, J. M., le Provost, F., Gounari, F., Bronson, R., von Boehmer, H., Taketo, M. M., Cardiff, R. D., Hennighausen, L. and Khazaie, K. (2002). Activation of beta-catenin signaling in differentiated mammary secretory cells induces transdifferentiation into epidermis and squamous metaplasias. Proc. Natl. Acad. Sci. USA 99, 219-224.
33. Mulder, K. M. (2000). Role of Ras and Mapks in TGFbeta signaling. Cytokine Growth Factor Rev. 11, 23-35.
34. Muraoka, R. S., Dumont, N., Ritter, C. A., Dugger, T. C., Brantley, D. M., Chen, J., Easterly, E., Roebuck, L. R., Ryan, S., Gotwals, P. J., Koteliansky, V. and Arteaga, C. L. (2002). Blockade of TGF-beta inhibits mammary tumor cell viability, migration, and metastases. J. Clin. Invest. 109, 1551-1559.
35. Nguyen, A. V. and Pollard, J. W. (2000). Transforming growth factor beta3 induces cell death during the first stage of mammary gland involution. Development 127, 3107-3118.
36. Oft, M., Akhurst, R. J. and Balmain, A. (2002). Metastasis is driven by sequential elevation of H-ras and Smad2 levels. Nat. Cell Biol. 4, 487-494.
37. Oft, M., Peli, J., Rudaz, C., Schwarz, H., Beug, H. and Reichmann, E. (1996). TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. Genes Dev. 10, 2462-2477.
38. Piek, E., Heldin, C. H. and ten Dijke, P. (1999a). Specificity, diversity, and regulation in TGF-beta superfamily signaling. FASEB J. 13, 2105-2124.
39. Piek, E., Moustakas, A., Kurisaki, A., Heldin, C. H. and ten Dijke, P. (1999b). TGF-(beta) type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells. J. Cell Sci. 112, 4557-4568.
40. Pierce, D. F., Jr, Gorska, A. E., Chytil, A., Meise, K. S., Page, D. L., Coffey, R. J., Jr and Moses, H. L. (1995). Mammary tumor suppression by transforming growth factor beta 1 transgene expression. Proc. Natl. Acad. Sci. USA 92, 4254-4258.
41. Polakis, P. (2001). More than one way to skin a catenin. Cell 105, 563-566.
42. Portella, G., Cumming, S. A., Liddell, J., Cui, W., Ireland, H., Akhurst, R. J. and Balmain, A. (1998). Transforming growth factor beta is essential for spindle cell conversion of mouse skin carcinoma in vivo: implications for tumor invasion. Cell Growth Differ. 9, 393-404.
43. Robinson, G. W. and Hennighausen, L. (1997). Inhibins and activins regulate mammary epithelial cell differentiation through mesenchymal-epithelial interactions. Development 124, 2701-2708.
44. Sasai, H., Masaki, M. and Wakitani, K. (2000). Suppression of polypogenesis in a new mouse strain with a truncated Apc(Delta474) by a novel COX-2 inhibitor, JTE-522. Carcinogenesis 21, 953-958.
45. Sinn, E., Muller, W., Pattengale, P., Tepler, I., Wallace, R. and Leder, P. (1987). Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo. Cell 49, 465-475.
46. Sirard, C., de la Pompa, J. L., Elia, A., Itie, A., Mirtsos, C., Cheung, A., Hahn, S., Wakeham, A., Schwartz, L., Kern, S. E., Rossant, J. and Mak, T. W. (1998). The tumor suppressor gene Smad4/Dpc4 is required for gastrulation and later for anterior development of the mouse embryo. Genes Dev. 12, 107-119.
47. Stambolic, V., Tsao, M. S., Macpherson, D., Suzuki, A., Chapman, W. B. and Mak, T. W. (2000). High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+/- mice. Cancer Res. 60, 3605-3611.
48. Tamura, G., Sakata, K., Nishizuka, S., Maesawa, C., Suzuki, Y., Terashima, M., Eda, Y. and Satodate, R. (1996). Allelotype of adenoma and differentiated adenocarcinoma of the stomach. J. Pathol. 180, 371-377.
49. Wagner, K. U., Wall, R. J., St-Onge, L., Gruss, P., Wynshaw-Boris, A., Garrett, L., Li, M., Furth, P. A. and Hennighausen, L. (1997). Cre-mediated gene deletion in the mammary gland. Nucleic Acids Res. 25, 4323-4330.
50. Wakefield, L. M., Piek, E. and Bottinger, E. P. (2001). TGF-beta signaling in mammary gland development and tumorigenesis. J Mamm. Gland Biol. Neoplasia 6, 67-82.
51. Wakefield, L. M. and Roberts, A. B. (2002). TGF-beta signaling: positive and negative effects on tumorigenesis. Curr. Opin. Genet. Dev. 12, 22-29.
52. Walker, R. A. (2000). Transforming growth factor beta and its receptors: their role in breast cancer. Histopathology 36, 178-180.
53. Weinstein, M., Yang, X. and Deng, C. (2000). Functions of mammalian Smad genes as revealed by targeted gene disruption in mice. Cytokine Growth Factor Rev. 11, 49-58.
54. Xu, X., Wagner, K. U., Larson, D., Weaver, Z., Li, C., Ried, T., Hennighausen, L., Wynshaw-Boris, A. and Deng, C. X. (1999). Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Nat. Genet. 22, 37-43.
55. Yang, X., Li, C., Xu, X. and Deng, C. (1998). The tumor suppressor SMAD4/DPC4 is essential for epiblast proliferation and mesoderm induction in mice. Proc. Natl. Acad. Sci. USA 95, 3667-3672.
56. Yang, X., Li, C., Herrera, P. L. and Deng, C. X. (2002a). Generation of Smad4/Dpc4 conditional knockout mice. Genesis 32, 80-81.
57. Yang, Y. A., Dukhanina, O., Tang, B., Mamura, M., Letterio, J. J., MacGregor, J., Patel, S. C., Khozin, S., Liu, Z. Y., Green, J., Anver, M. R., Merlino, G. and Wakefield, L. M. (2002b). Lifetime exposure to a soluble TGF-beta antagonist protects mice against metastasis without adverse side effects. J. Clin. Invest. 109, 1607-1615.